Bionano Genomics Inc To Acquire Purigen Biosystems Transcript
Good day, and welcome to the Bionano Genomics conference call regarding its acquisition of Purigen Biosystems. Today's conference is being recorded. At this time, I would like to turn the call over to Amy Conrad from Investor Relations. Please go ahead.
Thank you, Keith, and good morning, everyone. Welcome to the Bionano Genomics conference call, where we will be discussing the acquisition of Purigen Biosystems. Leading the call today is Dr. Erik Holmlin, CEO of Bionano. He is joined by Chris Stewart, CFO of Bionano; and Dr. Klint Rose, previously CFO and Co-Founder of Purigen, who are available for questions.
After market closed yesterday, Bionano issued a press release announcing Bionano and Purigen's entry into a merger agreement for the proposed acquisition of Purigen. A copy of the release can be found on the Investor Relations page of Bionano's website.
I would like to remind everyone that certain statements made during this conference call may be forward-looking, including statements about
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |